(Q46813794)

25 December 2017

meta-analysis

0 references

title

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes (English)

1 reference

25 December 2017

0 references

0 references

Susanne Rösner

1

1 reference

25 December 2017

Stefan Leucht

series ordinal

2

1 reference

25 December 2017

Philippe Lehert

series ordinal

3

1 reference

25 December 2017

Michael Soyka

series ordinal

4

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

25 December 2017

Journal of Psychopharmacology

published in

1 reference

25 December 2017

volume

22

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

11-23

1 reference

25 December 2017

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Efficacy of acamprosate in the treatment of alcohol-dependent outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Does acamprosate improve reduction of drinking as well as aiding abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Effectiveness of naltrexone in a community treatment program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Pharmacotherapy of alcohol dependence: a review of the clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Acamprosate and its efficacy in treating alcohol dependent adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Clock reset for alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Relapse coping and problem solving training following treatment for smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Effect of naltrexone on alcohol "high" in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Factors associated with lapses to heroin use during methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

Identification and impact of outcome selection bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107078308

21 January 2018

Identifiers

DOI

10.1177/0269881107078308

1 reference

25 December 2017

1 reference

25 December 2017